Skip to main content
Figure 1 | Lipids in Health and Disease

Figure 1

From: Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial

Figure 1

Apolipoprotein B/A1 ratio and other lipoproteins sub-fractions profile using quantimetrix Lipoprint™ system. The very low-density lipoprotein (VLDL) fraction, then the intermediate-density lipoprotein (IDL), the low-density lipoprotein (LDL) size which can distinguish the large LDL sub-fractions 1–2, non atherogenic, and the small dense LDL (sdLDL) sub-fractions 3–7, atherogenic, and the high-density lipoprotein (HDL) sub-fractions (large, intermediate and small). *: p < .05; **: p < .01; ***: p < .001 between different time of measurements for MetS participants. ‡: p < .05; ‡‡: p < .01; ‡‡‡: p < .001 between MetS participants and controls.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X